Intervention to Enhance PrEP Persistence

Abroad (travel likely)Recruiting

Conditions

HIV Prevention · HIV Infection Primary

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Whitman Walker Health, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Jowanna Malone, PhD, MSc) · jmalone@whitman-walker.org · 202-207-2499
University of Mississippi Medical Center, Jackson, Mississippi, United States
Contact: Study coordinator (Thomas Dobbs, MD) · tdobbs@umc.edu · (601) 984-5560
The Rhode Island Public Health Institute, Providence, Rhode Island, United States
Contact: Study coordinator (Amy Nunn, ScD) · amy.nunn@riphi.org · 401-863-6568

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

HIV · Hematologic Malignancies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

HIV · Prophylaxis · Injectable

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States

Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana

Cervical Cancer Screening · HIV · Self-sampling

Abroad (travel likely)Recruiting

Cape Coast, Ghana

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

HIV · Stimulant Use Disorder · Justice Involved Populations

Abroad (travel likely)Recruiting

New Haven, United States · Dallas, United States